Saturday , September 18 2021

COVID-19 Francisco Sagasti confirms that it is a “fantasy” to use a candidate for the Peruvian vaccine without “performing clinical trials” Coronavirus VIDEO nndc | EDITION

President Francisco Sagasti confirmed that the COVID-19 candidate project, developed by Mirko Zimic, head of the Laboratory for Bioinformatics, Molecular Biology and Technological Achievements at the University of Peru Cayetano Heredia (UPCH), with Farvet’s support, received government support. during the first two phases, but that is a “fantasy” to think about being used for the vaccination process that is being carried out en masse in the country.

Candidate for Vice President of the People’s Action threatened to call the High Police Command when she intervened (VIDEO)

In statements to reporters from the Ica region, where he led the delivery of supplies and medical equipment, the president explained that the study received funding from the National Institutes of Health (INS) to conduct the first two phases, laboratory tests and then with animals, but to date, clinical trials requiring the implementation of sophisticated procedures have not been initiated, as three-stage performance will be required to be tested on humans.

Francisco Sagasti on the Peruvian vaccine
Francisco Sagasti on the Peruvian vaccine

Sagasti explained that conducting a clinical trial of a candidate for the COVID-19 vaccine requires investment and time, which is why it is now difficult to do so in the country.

“Despite the fact that he talked to Mirko Zimić because the one who discovered and invented these vaccines, he cooperated with Mr. [Manolo Fernández, médico veterinario CEO del laboratorio] Farvet. We talked to him and he explained all the problems to fine tune that vaccine. Clinical trials must be conducted on thousands of people, in three phases. It takes time, it takes money, and this type of vaccine that has been produced is a special type for vaccine production, and no clinical trials can be conducted in Peru. “, He said.

Magaly Medina on Alfred Zambran: “I’m too old to mourn someone” (VIDEO)

“So they’re researching and we’ve supported them in that to see how this scientific discovery can be achieved, but also please don’t overdo it, to think that a vaccine that has not been done in clinical trials and that is widely used is a fantasy. Letters [Pongámos] standing on the ground, we provide all the support for a safe vaccine so that it goes through clinical trials and then we see how it can be produced ”he added.

Also, the head of state specified that the construction of a plant for the production of vaccines requires a very large investment. Let’s not think that the Peruvian vaccine will be available in a few months or early next year. My conversations with the researcher showed me the way very clearly and there are no shortcuts. You have to go step by step, but the vaccine had the support of the government. “, he remarked.

At the end of January this year, Manolo Fernandez, The CEO of Farvet-based veterinarian Farvet in Chinchi, assured El Comercia that after problems arose at his company, he would not proceed with the phase of clinical trials of candidates for the intranasal vaccine against COVID-19 he is developing. He reiterated that no one had been vaccinated and that his statements confirming this were a mistake of feeling.



AFP: how do I know how much money I have left in my pension fund

Source link